Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Pathology and Clinical Laboratory Medicine, |
RCV000017475 | SCV001438865 | likely pathogenic | Fanconi-Bickel syndrome | criteria provided, single submitter | clinical testing | ||
3billion, |
RCV000017475 | SCV002572710 | pathogenic | Fanconi-Bickel syndrome | 2022-09-01 | criteria provided, single submitter | clinical testing | The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.001%). Shared with similarly affected family member (3billion dataset). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.82; 3Cnet: 0.86). Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000016095). The variant has been reported to co-segregate with the disease in at least 5 similarly affected relatives/individuals in the same family or similarly affected unrelated family (PMID: 10987651). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. |
Genomic Medicine Center of Excellence, |
RCV000017475 | SCV004806209 | pathogenic | Fanconi-Bickel syndrome | 2024-03-25 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000017475 | SCV000037747 | pathogenic | Fanconi-Bickel syndrome | 1999-09-01 | no assertion criteria provided | literature only |